PATIENT DATA REPORTING WHITE PAPERS & ARTICLES

• Meeting The FDA's New Real-World Evidence Standards

  FDA guidance is reshaping RWE strategy. Sponsors that build interoperable, audit-ready RWD infrastructure now will be best positioned for faster, defensible submissions.

• The eCOA Iceberg

  Understand the true cost of eCOA deployment, beyond software licenses, to reduce protocol risk, avoid operational bottlenecks, and protect study timelines and data quality.

• Capture Was Step One. Execution Is Step Two.

  Electronic data capture transformed clinical trials, but advancing a study depends on decision workflows that interpret data, coordinate teams, and determine meaningful next actions.

• Case Studies In Clinical Trial Transformation

  Delve into how leading life sciences organizations are transforming their clinical trial execution through connected workflows, unified data ecosystems, and real-time decision-making.

• Optimizing Data Capture From Protocol Design To Efficacy Endpoints

  The shift to digital trials favors the 11-point NRS over the traditional VAS to reduce data noise, improve elderly patient compliance, and ensure statistical power across mobile devices.